Phase I Study To Assess Pharmacokinetics (Pk), Qt/Qtc Effect, And Safety Of Amrubicin In Patients (Pts) With Advanced Solid Tumors

JOURNAL OF CLINICAL ONCOLOGY(2011)

引用 0|浏览8
暂无评分
摘要
7073 Background: Amrubicin (AMR), a 3rd-generation synthetic anthracycline has shown promising activity in solid tumors, including small cell lung cancer (SCLC) without cardiotoxicity. This intensi...
更多
查看译文
关键词
amrubicin,pharmacokinetics,qt/qtc effect,advanced solid tumors
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要